AR084815A1 - Compuestos analgesicos, metodos y formulaciones - Google Patents
Compuestos analgesicos, metodos y formulacionesInfo
- Publication number
- AR084815A1 AR084815A1 ARP120100071A ARP120100071A AR084815A1 AR 084815 A1 AR084815 A1 AR 084815A1 AR P120100071 A ARP120100071 A AR P120100071A AR P120100071 A ARP120100071 A AR P120100071A AR 084815 A1 AR084815 A1 AR 084815A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- phenyl
- methods
- formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/50—Spiro compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a compuestos, y sales de los mismos de fórmula (1) en donde A es un compuesto de fórmula (2); R1 es hidrógeno, alquilo C1-5, alcoxi C1-5, haloalquilo C1-5, alcanol C1-5, -(alquil C1-5)fenilo, o fenilo, o un grupo de la fórmula -C(O)-R12, donde R12 puede ser alquilo C1-5, alcoxi C1-5, haloalquilo C1-5, alcanol C1-5, -(alquil C1-5)fenilo, o fenilo; R2 y R3 son independientemente hidrógeno, alquilo C1-5, alcoxi C1-5, halógeno, haloalquilo C1-5, o haloalcoxi C1-5; R4 y R5 son independientemente hidrógeno, alquilo C1-5, o -(alquil C1-5)fenilo; R6 es hidrógeno, hidroxi, o está ausente; R7 es hidrógeno; R8 y R9 son independientemente hidrógeno o metilo; R10 es hidrógeno; R11 es hidrógeno o alquilo C1-5; o R7 y R10 se combinan para formar -CH2- o -(CH2)2-; o R8 y R9 se combinan para formar un grupo ciclopropilo con el carbono al cual están unidos; o R10 y R11 se combinan para formar -CH2- o -(CH2)3-. Adicionalmente, se proporcionan formulaciones farmacéuticas y métodos de uso que emplean los compuestos anteriores.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2011/070706 WO2012100423A1 (en) | 2011-01-27 | 2011-01-27 | Analgesic compounds, methods, and formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
AR084815A1 true AR084815A1 (es) | 2013-06-26 |
Family
ID=45558412
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120100071A AR084815A1 (es) | 2011-01-27 | 2012-01-10 | Compuestos analgesicos, metodos y formulaciones |
ARP220101618A AR126189A2 (es) | 2011-01-27 | 2022-06-21 | Compuestos analgésicos, métodos y formulaciones |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220101618A AR126189A2 (es) | 2011-01-27 | 2022-06-21 | Compuestos analgésicos, métodos y formulaciones |
Country Status (22)
Country | Link |
---|---|
US (1) | US8802728B2 (es) |
EP (1) | EP2668152B1 (es) |
JP (1) | JP6002153B2 (es) |
KR (1) | KR101612168B1 (es) |
CN (2) | CN103328433B (es) |
AR (2) | AR084815A1 (es) |
AU (1) | AU2012209430B2 (es) |
BR (1) | BR112013018527B1 (es) |
CA (1) | CA2825816C (es) |
CL (1) | CL2013002102A1 (es) |
CO (1) | CO6781505A2 (es) |
EA (1) | EA024101B1 (es) |
ES (1) | ES2612495T3 (es) |
IL (1) | IL227250A (es) |
IN (1) | IN2013MN01164A (es) |
MX (1) | MX345518B (es) |
MY (1) | MY163262A (es) |
SG (1) | SG192131A1 (es) |
TW (1) | TWI564275B (es) |
UA (1) | UA110122C2 (es) |
WO (2) | WO2012100423A1 (es) |
ZA (1) | ZA201304786B (es) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1199764B (de) * | 1963-04-02 | 1965-09-02 | Gruenenthal Chemie | Verfahren zur Herstellung von basisch substituierten Phenolaethern |
DE1518663A1 (de) * | 1965-08-02 | 1969-12-18 | Gruenenthal Chemie | Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung |
US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
DE19547766A1 (de) * | 1995-12-20 | 1997-06-26 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe |
DE19805370A1 (de) * | 1997-03-14 | 1998-09-17 | Gruenenthal Gmbh | Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen |
ES2141688B1 (es) * | 1998-11-06 | 2001-02-01 | Vita Invest Sa | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. |
DE10049481A1 (de) * | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte C-Cyclohexylmethylamin-Derivate |
DE10049483A1 (de) | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte 1-Aminobutan-3-ol-Derivate |
US6780891B2 (en) * | 2001-11-30 | 2004-08-24 | Sepracor Inc. | Tramadol analogs and uses thereof |
US20050182131A1 (en) | 2002-07-19 | 2005-08-18 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence |
DE10233048A1 (de) * | 2002-07-19 | 2004-01-29 | Grünenthal GmbH | Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken |
EP2022778A1 (en) * | 2007-08-07 | 2009-02-11 | Laboratorios del Dr. Esteve S.A. | A crystalline form of (R,R)-tramadol-(S)-naproxene salt |
-
2011
- 2011-01-27 WO PCT/CN2011/070706 patent/WO2012100423A1/en active Application Filing
-
2012
- 2012-01-10 AR ARP120100071A patent/AR084815A1/es active IP Right Grant
- 2012-01-13 JP JP2013551992A patent/JP6002153B2/ja active Active
- 2012-01-13 EP EP12701809.1A patent/EP2668152B1/en active Active
- 2012-01-13 TW TW101101513A patent/TWI564275B/zh active
- 2012-01-13 ES ES12701809.1T patent/ES2612495T3/es active Active
- 2012-01-13 SG SG2013056627A patent/SG192131A1/en unknown
- 2012-01-13 MX MX2013008708A patent/MX345518B/es active IP Right Grant
- 2012-01-13 MY MYPI2013701314A patent/MY163262A/en unknown
- 2012-01-13 CA CA2825816A patent/CA2825816C/en active Active
- 2012-01-13 UA UAA201308974A patent/UA110122C2/uk unknown
- 2012-01-13 WO PCT/US2012/021181 patent/WO2012102875A2/en active Application Filing
- 2012-01-13 AU AU2012209430A patent/AU2012209430B2/en active Active
- 2012-01-13 CN CN201280006664.8A patent/CN103328433B/zh active Active
- 2012-01-13 BR BR112013018527-9A patent/BR112013018527B1/pt active IP Right Grant
- 2012-01-13 EA EA201390857A patent/EA024101B1/ru not_active IP Right Cessation
- 2012-01-13 IN IN1164MUN2013 patent/IN2013MN01164A/en unknown
- 2012-01-13 KR KR1020137022533A patent/KR101612168B1/ko active IP Right Grant
- 2012-01-13 CN CN201610195255.7A patent/CN105753723B/zh active Active
- 2012-01-13 US US13/883,803 patent/US8802728B2/en active Active
-
2013
- 2013-06-26 ZA ZA2013/04786A patent/ZA201304786B/en unknown
- 2013-06-27 IL IL227250A patent/IL227250A/en active IP Right Grant
- 2013-07-23 CL CL2013002102A patent/CL2013002102A1/es unknown
- 2013-07-26 CO CO13177731A patent/CO6781505A2/es active IP Right Grant
-
2022
- 2022-06-21 AR ARP220101618A patent/AR126189A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS54175B1 (en) | BROMODOMEN INHIBITORS AND THEIR APPLICATION | |
AR088668A1 (es) | Moleculas pequeñas que contienen boro | |
RS53395B (en) | DERIVATIVES N1-SULFONIL-5-FLUORPIRIMIDINONA | |
CO6210729A2 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona procedimientos para su preparacion y su uso como agente farmaceutico | |
PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
AR082562A1 (es) | Derivados de isoxazolina como agentes antiparasitarios | |
CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
AR093184A1 (es) | Compuesto de pirimidina sustituida como inhibidor de quinurenina-3-monooxigenasa y composicion farmaceutica que lo comprenden | |
AR094262A1 (es) | Compuestos antivirales para el tratamiento de la hepatitis c | |
AR097431A1 (es) | Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim | |
AR087288A1 (es) | Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a | |
AR077292A1 (es) | Derivados de piperazin - quinolin sulfonamidas y composiciones farmaceuticas | |
ECSP12012293A (es) | Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos | |
AR067759A1 (es) | Compuestos de pirazol utiles como moduladores de la enzima raf asociada al crecimiento celular anormal | |
AR087549A1 (es) | Derivados de 5-fluor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona | |
AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
EA201170118A1 (ru) | Циклопропильные ингибиторы полимеразы | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
AR079662A1 (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa | |
AR065157A1 (es) | Compuestos de 6-bencil- 2,3,4,7-tetrahidro-indolo [2,3-c] quinolina | |
AR092971A1 (es) | Inhibidores de agrecanasa | |
AR075951A1 (es) | Dihidropiridin sulfonamidas y dihidropiridin sulfamidas como inhibidores de mek | |
AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |